Larsen Maiken K, Nissen Peter H, Kristensen Ingrid B, Jensen Henrik K, Banner Jytte
Department of Forensic Medicine, Faculty of Health Sciences, Aarhus University, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark.
J Forensic Sci. 2012 May;57(3):658-62. doi: 10.1111/j.1556-4029.2011.02028.x. Epub 2012 Jan 4.
Familial hypercholesterolemia (FH) is a genetic disorder that may lead to premature coronary heart disease (CHD) and sudden cardiac death (SCD). Mutations in the LDLR or APOB genes cause FH. We have screened the LDLR and the ligand-binding region of APOB genes in 52 cases of SCD. Deceased patients were younger than 40 years of age and were suspected of having FH. The LDLR and APOB genes were examined via PCR, high-resolution melting, and DNA sequencing. Therein, it was observed that 7.7% of the screened patients exhibited a rare sequence variant in the LDLR gene, with 5.7% suspected of being pathogenic mutations. Lipid profiles and genetic testing for FH could be considered when autopsy reveals significant atherosclerosis of the coronary arteries in young adults. First-degree family members are advised to seek medical advice and testing to determine their own risks of atherosclerosis to prevent premature CHD and SCD.
家族性高胆固醇血症(FH)是一种遗传性疾病,可能导致早发性冠心病(CHD)和心源性猝死(SCD)。LDLR或APOB基因的突变会导致FH。我们对52例SCD患者的LDLR和APOB基因的配体结合区域进行了筛查。已故患者年龄小于40岁,疑似患有FH。通过聚合酶链反应(PCR)、高分辨率熔解分析和DNA测序对LDLR和APOB基因进行检测。其中,观察到7.7%的筛查患者在LDLR基因中表现出罕见的序列变异,5.7%疑似为致病突变。当尸检显示年轻成年人冠状动脉存在明显动脉粥样硬化时,可考虑进行FH的血脂谱和基因检测。建议一级家庭成员寻求医疗建议和检测,以确定自身患动脉粥样硬化的风险,预防早发性冠心病和心源性猝死。